Tuesday, April 05, 2005 11:24:11 PM
The pps says nothing about the company.
The pps IS the company.
You can't possibly pretend that the future, if not the near term survival, of the company is not tied DIRECTLY to the pps.
Whether the future 'du jour' is based on the $25 Million to purchase Biofrontera or the $20 Million needed for a drug trial, that money HAS to be extracted from the investment community via sales of shares.
Forgetting the obvious dilutive effects of printing shares, $20 Million dollars will require 2 Billion shares and a MINIMUM share price of one cent.
Neither value is currently viable. The pps MUST respond if the company is to survive.
They are inextricably connected.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM